Allurion Technologies Inc. (ALUR)
NYSE: ALUR · Real-Time Price · USD
1.840
+0.160 (9.52%)
At close: Jan 12, 2026, 4:00 PM EST
1.920
+0.080 (4.35%)
After-hours: Jan 12, 2026, 7:59 PM EST
Allurion Technologies Market Cap
Allurion Technologies has a market cap or net worth of $22.61 million as of January 12, 2026. Its market cap has increased by 0.55% in one year.
Market Cap
22.61M
Enterprise Value
99.77M
1-Year Change
0.55%
Ranking
Category
Stock Price
$1.84
Market Cap Chart
Since March 29, 2021, Allurion Technologies's market cap has decreased from $995.03M to $22.61M, a decrease of -97.73%. That is a compound annual growth rate of -54.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 20.65M | 36.59% |
| Dec 31, 2025 | 15.12M | -48.13% |
| Dec 31, 2024 | 29.15M | -83.58% |
| Dec 29, 2023 | 177.54M | -82.67% |
| Dec 30, 2022 | 1.02B | 3.80% |
| Dec 31, 2021 | 986.91M | -0.82% |
| Mar 29, 2021 | 995.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |